A kutatk gy vlik, hogy a szilimarin a sejtkrosods megelzsvel kpes fenntartani a glutationszintet (23)
Meanwhile, research suggests the plasma half-life of Semaglutide is 46h following i.v
The authors noted that results from more recent studies were less positive than those from earlier studies, and concluded that routine clinical use of ALCAR to treat dementia signs and symptoms was not justified [15]
Clinical trials show average weight loss of 15 to 17 percent of body weight over 68 weeks
Ros structure: nurse coaching (not a behavior-change curriculum), async messaging, plus food noise research across 35,000 patients at ObesityWeek 2025
However, they must not be combined with GLP-1 receptor agonists, and caution is needed when used with sulfonylureas or insulin due to an increased risk of hypoglycaemia